| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option?
|
Krieger, Otto
|
|
2010
|
3 |
1 |
p. 16-18
|
artikel
|
| 2 |
Austrian consensus recommendations for the treatment of patients with multiple myeloma
|
Gunsilius, E.
|
|
2010
|
3 |
1 |
p. 7-10
|
artikel
|
| 3 |
Biomarkers of angiogenesis and their role in clinical oncology
|
Pircher, Andreas
|
|
2010
|
3 |
1 |
p. 27-32
|
artikel
|
| 4 |
CECOG’s services at a glance
|
Zielinski, Christoph C.
|
|
2010
|
3 |
1 |
p. 41
|
artikel
|
| 5 |
Changing paradigms in clinical trials
|
Hilbe, W.
|
|
2010
|
3 |
1 |
p. 1-2
|
artikel
|
| 6 |
Fibroblast growth factor receptors (FGFR) as possible therapeutic targets in human non-small cell lung cancer
|
Grusch, M.
|
|
2010
|
3 |
1 |
p. 23-26
|
artikel
|
| 7 |
Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature
|
Sun, W. L.
|
|
2010
|
3 |
1 |
p. 19-22
|
artikel
|
| 8 |
Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines
|
Pfeilstöcker, Michael
|
|
2010
|
3 |
1 |
p. 11-15
|
artikel
|
| 9 |
Qualitative and quantitative assessment of endpoints in clinical trials
|
Fridrik, Michael A.
|
|
2010
|
3 |
1 |
p. 33-36
|
artikel
|
| 10 |
Stemming cancer by Hedgehog pathway inhibition: from flies to bedside
|
Aberger, Fritz
|
|
2010
|
3 |
1 |
p. 3-6
|
artikel
|
| 11 |
Swiss trials in thoracic oncology
|
Gautschi, O.
|
|
2010
|
3 |
1 |
p. 37-40
|
artikel
|
Tijdschrift beschrijving